Evaluation of the Functional Status Questionnaire in Heart Failure: A Sub-study of the Second Cardiac Insufficiency Bisoprolol Survival Study (CIBIS-II)

被引:8
|
作者
Gallanagh, Siobhan [1 ]
Castagno, Davide [1 ,2 ]
Wilson, Ben [1 ]
Erdmann, Erland [3 ]
Zannad, Faiez [4 ]
Remme, Willem J. [5 ]
Lopez-Sendon, Jose L. [6 ]
Lechat, Philippe [13 ]
Follath, Ferenc [12 ]
Hoglund, Christer [11 ]
Mareev, Viacheslav [10 ]
Sadowski, Zygmunt [9 ]
Seabra-Gomes, Ricardo J. [8 ]
Dargie, Henry J. [7 ]
McMurray, John J. V. [1 ]
机构
[1] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland
[2] Univ Turin, Cardiol Unit, Dept Internal Med, Turin, Italy
[3] Univ Cologne, Dept Internal Med 3, Cologne, Germany
[4] Univ Nancy, Nancy, France
[5] Sticares Cardiovasc Res Inst, Rhoon, Netherlands
[6] Univ Hosp La Paz, Dept Cardiol, Madrid, Spain
[7] Golden Jubilee Natl Hosp, Clydebank, Glasgow, Lanark, Scotland
[8] Hosp Santa Cruz, Dept Cardiol, Carnaxide, Portugal
[9] Natl Inst Cardiol, Warsaw, Poland
[10] AL Myasnikov Cardiol Inst, Moscow, Russia
[11] Stockholm Heart Ctr, Stockholm, Sweden
[12] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[13] UPMC, Hop La Pitie Salpetriere, APHP, Dept Pharmacol, Paris, France
关键词
Heart failure; Quality of life; Functional status questionnaire; Minnesota living with heart failure questionnaire; QUALITY-OF-LIFE; DOUBLE-BLIND; CARVEDILOL; MORTALITY; PAIN;
D O I
10.1007/s10557-011-6284-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We evaluated a generic quality of life (QoL) Functional Status Questionnaire (FSQ), in patients with chronic heart failure (CHF). The FSQ assesses the 3 main dimensions of QoL: physical functioning, mental health and social role. It also includes 6 single item questions about: work status, frequency of social interactions, satisfaction with sexual relationships, days in bed, days with restricted activity and overall satisfaction with health status. The FSQ was compared to the Minnesota Living with Heart Failure questionnaire (MLwHF). The FSQ was evaluated in a substudy (n = 340) of the second Cardiac Insufficiency Bisoprolol Survival study (CIBIS-II), a placebo-controlled mortality trial. 265 patients (75%) patients completed both questionnaires at 6 months of follow-up. Both questionnaires indicated substantially impaired QoL. The FSQ demonstrated high internal consistency (Cronbach's alpha > 0.7 for all items except "social activity"aEuro parts per thousand= 0.66) and construct and concurrent validity. After 6 months, the only item on either questionnaire to show a difference between the placebo- and bisoprolol-treatment groups was the single item FSQ question about "days in bed" (p = 0.018 in favour of bisoprolol). The FSQ performed well in this study, provided additional information to the MLwHF questionnaire and allowed interesting comparisons with other chronic medical conditions. The FSQ may be a useful general QoL instrument for studies in CHF.
引用
收藏
页码:77 / 85
页数:9
相关论文
共 50 条
  • [1] Evaluation of the Functional Status Questionnaire in Heart Failure: A Sub-study of the Second Cardiac Insufficiency Bisoprolol Survival Study (CIBIS-II)
    Siobhan Gallanagh
    Davide Castagno
    Ben Wilson
    Erland Erdmann
    Faiez Zannad
    Willem J. Remme
    José L. Lopez-Sendon
    Philippe Lechat
    Ferenc Follath
    Christer Höglund
    Viacheslav Mareev
    Zygmunt Sadowski
    Ricardo J. Seabra-Gomes
    Henry J. Dargie
    John J. V. McMurray
    Cardiovascular Drugs and Therapy, 2011, 25 : 77 - 85
  • [2] Reduced costs with bisoprolol treatment for heart failure -: An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II)
    Bacquet, P
    Lévy, E
    McGuire, A
    McMurray, J
    Mérot, JL
    Paschen, B
    Remme, WJ
    Szucs, TD
    Klein, W
    Brunhuber, W
    Hofmann, R
    Kühn, P
    Nesser, HJ
    Slany, J
    Weihs, W
    Wiedermann, C
    Wimmer, H
    van Mieghem, W
    Boland, J
    Chaudron, JM
    Jordaens, L
    Melchior, JP
    Aschermann, M
    Bruthansl, J
    Hradec, M
    Kölbel, F
    Semrád, B
    Haghfelt, T
    Hansen, JF
    Goetzsche, CO
    Hildebrandt, P
    Kassis, E
    Rasmussen, V
    Rokkedal, J
    Thomassen, A
    Groundstroem, K
    Uusimaa, P
    Le Heuzey, JY
    Aumont, MC
    Aupetit, JF
    Baille, N
    Baudouy, P
    Belin, A
    Bonneau, A
    Bonneric, G
    Bousser, JP
    Citron, B
    Dary, P
    Decoulx, E
    De Groote, P
    EUROPEAN HEART JOURNAL, 2001, 22 (12) : 1021 - 1031
  • [3] Reduced costs with bisoprolol treatment for heart failure:: an economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II)
    McMurray, JJV
    Bacquet, P
    Lévy, E
    McGuire, A
    Mérot, JL
    Pachen, B
    Remme, WJ
    EUROPEAN HEART JOURNAL, 2000, 21 : 151 - 151
  • [4] Review of the cardiac insufficiency bisoprolol study II (CIBIS-II)
    LeJemtel T.H.
    Current Cardiology Reports, 1999, 1 (1) : 29 - 30
  • [5] Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial
    Castagno, Davide
    Jhund, Pardeep S.
    McMurray, John J. V.
    Lewsey, James D.
    Erdmann, Erland
    Zannad, Faiez
    Remme, Willem J.
    Lopez-Sendon, Jose L.
    Lechat, Philippe
    Follath, Ferenc
    Hoglund, Christer
    Mareev, Viacheslav
    Sadowski, Zygmunt
    Seabra-Gomes, Ricardo J.
    Dargie, Henry J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (06) : 607 - 616
  • [6] The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II):: a randomised trial
    Lechat, P
    Brunhuber, KW
    Hofmann, R
    Kühn, P
    Nesser, HJ
    Slany, J
    Weihs, W
    Wiedermann, C
    Wimmer, H
    van Mieghem, W
    Boland, J
    Chaudron, JM
    Jordaens, L
    Melchior, JP
    Aschermann, M
    Bruthansl, J
    Hradec, M
    Kölbel, F
    Semrád, B
    Haghfelt, T
    Fischer-Hansen, J
    Goetzsche, CO
    Hildebrandt, P
    Kassis, E
    Rasmussen, V
    Rokkedal, J
    Thomassen, A
    Groundstroem, K
    Uusimaa, P
    Le Heuzey, JY
    Aumont, MC
    Aupetit, JF
    Baille, N
    Baudouy, P
    Belin, A
    Bonneau, A
    Bonneric, G
    Bousser, JP
    Citron, B
    Dary, P
    Decoulx, E
    De Groote, P
    Denolle, T
    Dievart, F
    Duriez, P
    Eicher, JC
    Enjuto, G
    Ferrière, M
    Fournier, E
    Garandeau, M
    LANCET, 1999, 353 (9146): : 9 - 13
  • [7] Effect of bisoprolol on perioperative mortality and morbidity in patients with chronic heart failure (cardiac insufficiency bisoprolol study II (CIBIS II))
    Maack, C
    Böhm, M
    Wehrlen-Grandjean, M
    Erdmann, E
    EUROPEAN HEART JOURNAL, 2001, 22 : 263 - 263
  • [8] Design of the cardiac insufficiency bisoprolol study II (CIBIS II)
    Dargie, H
    Lechat, P
    Zannad, F
    Remme, WJ
    Erdmann, E
    Hoglund, C
    Sendon, JLL
    Follath, F
    Gomes, RJS
    Sadowski, Z
    Mareyev, V
    WehrlenGrandjean, M
    Brentano, CF
    Hohnloser, S
    Vanoli, E
    Hansen, S
    Jaillon, P
    Hill, C
    Sahlstrom, U
    DeBacker, G
    Leizorovicz, A
    Leizorovicz, A
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1997, 11 (02) : 138 - 142
  • [9] Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II))
    Böhm, M
    Maack, C
    Wehrlen-Grandjean, M
    Erdmann, E
    ZEITSCHRIFT FUR KARDIOLOGIE, 2003, 92 (08): : 668 - 676
  • [10] Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II))Bisoprolol und perioperative Komplikationen chirurgischer Eingriffe bei chronischer Herzinsuffizienz Cardiac Insufficiency Bisoprolol Study II (CIBIS II))
    M. Böhm
    C. Maack
    M. Wehrlen-Grandjean
    E. Erdmann
    Zeitschrift für Kardiologie, 2003, 92 (8): : 668 - 676